The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes (PRO) in patients (pts) with advanced or recurrent dMMR/MSI-H endometrial cancer (EC) treated with dostarlimab in the GARNET trial.
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Merck Sharp & Dohme; Roche/Genentech; Tesaro
Consulting or Advisory Role - Basilea; Cerulean Pharma; Clovis Oncology; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; Valirx
 
Cara Amanda Mathews
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Deciphera (Inst); Seagen (Inst); Syros Pharmaceuticals (Inst); Tesaro/GSK (Inst)
 
Andrés Redondo
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche
Research Funding - Eisai (Inst); PharmaMar (Inst); Roche (Inst)
 
Joice Huang
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Laurie Eliason
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Ellie Im
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Jubilee Brown
Honoraria - Clovis Oncology; Tesaro
Consulting or Advisory Role - Clovis Oncology; Olympus; Tesaro
Research Funding - Genentech; Tesaro
Travel, Accommodations, Expenses - Olympus